Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New broad-spectrum anti-MRSA pyrrolidinone cephalosporin and water-soluble prodrug from Roche

Oct. 6, 1998

The PAF antagonist MFH-1 shows potential as an adjunct in the therapy of AIDS

Oct. 6, 1998

New lead anti-HIV compound discovered by Italian university researchers

Oct. 6, 1998

Abbott obtains new ketolides with improved activity against MLS-resistant strains

Oct. 6, 1998

Novel acid-stable macrolides from Abbott presented at ICAAC

Oct. 6, 1998

MiKasome phase I data presented at ICAAC; development update

Oct. 6, 1998

Preclinical profile of BI-397, a promising new glycopeptide antibiotic

Oct. 6, 1998

Bayer's moxifloxacin highlighted at ICAAC; approval to be sought soon

Oct. 5, 1998

Preliminary phase II data and preclinical results reported for MK-826

Oct. 5, 1998

Bisphosphonate-conjugated antibacterials for targeted drug delivery in bone infections

Oct. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...